Suturing Through-the-scope System Used for Prophylactic Closure of Colonic Post-ESD Defects
Launched by ISTITUTO CLINICO HUMANITAS · Jun 3, 2024
Trial Information
Current as of February 18, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Large superficial colonic polyps are increasingly detected thanks to colorectal cancer screening programs worldwide. ESD is the technique which provides a high-quality resection of these large polyps.
Nevertheless, several adverse events affect ESD, especially in the colon. They could be life-threatening, call for or prolong the hospitalization, require blood transfusion, additional endoscopic or surgical procedures and increase costs.
Thus, preventing these adverse events is an important clinical and medico-economic objective. Endoscopic closure of post-ESD defects could reduce this risk...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient suffering from 30-60 mm colonic polyps with indication of ESD
- • Male or female patients aged \> 18 years' old
- • Patients able to fill in questionnaires written in Italian
- Exclusion Criteria:
- • Failure of endoscopic resection
- • Suspicion of deep submucosal cancer by analysis of pit pattern (KUDO Vn)
- • Polyp involving the appendix deeply (type 2 or 3 according to Toyonaga classification)
- • Polyp inside the ileo-cecal valvula.
- • Rectal lesions
Trial Officials
Alessandro Repici, Prof.
Principal Investigator
IRCCS Humanitas Research Hospital - Rozzano 20089, Milan, Italy
About Istituto Clinico Humanitas
Istituto Clinico Humanitas is a leading clinical research organization based in Italy, dedicated to advancing medical science through innovative clinical trials and research initiatives. With a strong emphasis on patient-centered care and cutting-edge methodologies, the institute collaborates with various stakeholders in the healthcare sector to develop and evaluate new therapies and treatment protocols. Its multidisciplinary team of experts is committed to ensuring the highest standards of ethical practice and scientific rigor, contributing to significant advancements in medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0